Neil Kumar

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Palo Alto, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Will Solis, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Neil Kumar

Form 4 holding Chief Executive Officer, Director

BridgeBio Pharma, Inc.

Security class
Common Stock
Shares / value
3,568,447
Estimated value
$265,777,932
Report date
18 Aug 2026
Price
$74.48
Ownership
By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Form 4 holding Chief Executive Officer, Director

BridgeBio Pharma, Inc.

Security class
Common Stock
Shares / value
505,686
Estimated value
$43,312,005
Report date
19 Aug 2026
Price
$85.65
Ownership
By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Form 4 holding Director

LianBio

Security class
Ordinary Shares
Shares / value
5,002,792
Estimated value
$8,270,616
Report date
29 Oct 2021
Price
$1.65
Ownership
By BridgeBio Pharma LLC
Form 4 holding Chief Executive Officer, Director

BridgeBio Pharma, Inc.

Security class
Restricted Stock Units
Shares / value
91,274
Estimated value
$6,023,201
Report date
16 Aug 2026
Price
$32.58
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

BridgeBio Pharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
40,570
Estimated value
Report date
17 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Neil Kumar

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .